145 related articles for article (PubMed ID: 31904350)
1. Immunological role and underlying mechanisms of B7-H6 in tumorigenesis.
Hu Y; Zeng T; Xiao Z; Hu Q; Li Y; Tan X; Yue H; Wang W; Tan H; Zou J
Clin Chim Acta; 2020 Mar; 502():191-198. PubMed ID: 31904350
[TBL] [Abstract][Full Text] [Related]
2. The potential of B7-H6 as a therapeutic target in cancer immunotherapy.
Mohammadi A; Najafi S; Amini M; Mansoori B; Baghbanzadeh A; Hoheisel JD; Baradaran B
Life Sci; 2022 Sep; 304():120709. PubMed ID: 35697295
[TBL] [Abstract][Full Text] [Related]
3. The B7 Family Member B7-H6: a New Bane of Tumor.
Chen Y; Mo J; Jia X; He Y
Pathol Oncol Res; 2018 Oct; 24(4):717-721. PubMed ID: 29086181
[TBL] [Abstract][Full Text] [Related]
4. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
5. B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
Banu N; Riera-Leal A; Haramati J; Ortiz-Lazareno PC; Panikar SS; Bastidas-Ramirez BE; Gutierrez-Silerio GY; Solorzano-Ibarra F; Tellez-Bañuelos MC; Gutierrez-Franco J; Bueno-Topete MR; Pereira-Suarez AL; Del Toro-Arreola S
BMC Cancer; 2020 Nov; 20(1):1083. PubMed ID: 33172426
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction.
Müller T; Schlahsa L; Zhang HJ; Skaik Y; Eiz-Vesper B; Immenschuh S; Blasczyk R; Figueiredo C
J Biol Regul Homeost Agents; 2014; 28(2):183-93. PubMed ID: 25001651
[TBL] [Abstract][Full Text] [Related]
7. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
[TBL] [Abstract][Full Text] [Related]
8. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
Qiu H; Gao S; Sun Z; Wang J
APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
[TBL] [Abstract][Full Text] [Related]
10. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
[TBL] [Abstract][Full Text] [Related]
11. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
[TBL] [Abstract][Full Text] [Related]
12. [Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review].
Wu FF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):295-8. PubMed ID: 26913440
[TBL] [Abstract][Full Text] [Related]
13. B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas.
Che F; Xie X; Wang L; Su Q; Jia F; Ye Y; Zang L; Wang J; Li H; Quan Y; You C; Yin J; Wang Z; Li G; Du Y; Wang L
Int Immunopharmacol; 2018 Jun; 59():318-327. PubMed ID: 29679856
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma.
Wu F; Wang J; Ke X
Int J Oncol; 2016 Apr; 48(4):1561-70. PubMed ID: 26891663
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
[TBL] [Abstract][Full Text] [Related]
16. The novel non-immunological role and underlying mechanisms of B7-H3 in tumorigenesis.
Zhou X; Ouyang S; Li J; Huang X; Ai X; Zeng Y; Lv Y; Cai M
J Cell Physiol; 2019 Dec; 234(12):21785-21795. PubMed ID: 31222741
[TBL] [Abstract][Full Text] [Related]
17. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
Schlecker E; Fiegler N; Arnold A; Altevogt P; Rose-John S; Moldenhauer G; Sucker A; Paschen A; von Strandmann EP; Textor S; Cerwenka A
Cancer Res; 2014 Jul; 74(13):3429-40. PubMed ID: 24780758
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.
Xu X; Narni-Mancinelli E; Cantoni C; Li Y; Guia S; Gauthier L; Chen Q; Moretta A; Vély F; Eisenstein E; Rangarajan S; Vivier E; Mariuzza RA
J Mol Biol; 2016 Nov; 428(22):4457-4466. PubMed ID: 27663271
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
20. B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer.
Zhou Y; Xu Y; Chen L; Xu B; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9428-33. PubMed ID: 26464699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
